Evalve, Inc. [a wholly owned subsidiary of Abbott Vascular, Inc.]

Evalve was incorporated in 1999 to design, develop, manufacture and market innovative devices to enable percutaneous repair of cardiac valves. The company’s initial products are intended to reduce the risks, trauma and cost associated with current open, arrested heart surgical options. The company’s present development and clinical efforts are focused on mitral valve repair with the MitraClip® system.

Evalve obtained CE mark approval in 2008 for the MitraClip® system, the world’s first percutaneous valve repair system.

In October, 2009 Evalve, Inc. was acquired by Abbott Vascular, Inc.

Visit us at www.abbottvascular.com for current information about the company.

Company’s Keywords:

biotechnology, life sciences, interventional cardiology